tiprankstipranks
CTT Pharmaceutical Holdings Inc (CTTH)
OTHER OTC:CTTH
US Market
CTTH
CTT Pharmaceutical Holdings
RESEARCH TOOLSreports

CTT Pharmaceutical Holdings (CTTH) Income Statement

9 Followers

CTT Pharmaceutical Holdings Income Statement

Last quarter (Q4 2025), CTT Pharmaceutical Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, CTT Pharmaceutical Holdings's net income was $-50.26K. See CTT Pharmaceutical Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.43K$ -6.40K$ -6.40K$ -6.40K$ 0.00
Operating Expenses
$ 120.34K$ 243.83K$ 35.70K$ 102.41K$ 148.45K
Depreciation and Amortization
$ 6.43K$ 6.40K$ 6.40K$ 6.40K$ 236.56K
EBITDA
$ -120.34K$ -243.83K$ -35.70K$ -44.71K$ 103.56K
Operating Income
$ -126.77K$ -250.00K$ -42.09K$ -109.00K$ -148.00K
Other Income/Expenses
$ -29.14K$ 40.00K$ -125.00$ 55.35K$ 15.38K
Pretax Income
$ -155.91K$ -210.00K$ -42.22K$ -53.45K$ -133.00K
Net Income
$ -155.91K$ -210.00K$ -42.22K$ -53.45K$ -133.00K
Per Share Metrics
Basic EPS
$ >-0.01$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ >-0.01$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
 57.57M 52.40M 50.53M 49.42M 50.07M
Weighted Average Shares Outstanding (Diluted)
 57.57M 52.40M 50.53M 49.42M 50.07M
Currency in USD

CTT Pharmaceutical Holdings Earnings and Revenue History